A detailed history of Steward Financial Group LLC transactions in Nymox Pharmaceutical Corp stock. As of the latest transaction made, Steward Financial Group LLC holds 100 shares of NYMX stock, worth $47. This represents 0.0% of its overall portfolio holdings.

Number of Shares
100
Holding current value
$47
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Oct 20, 2023

BUY
$0.2 - $1.03 $20 - $103
100 New
100 $0
Q4 2022

Feb 13, 2023

BUY
$0.28 - $0.74 $28 - $74
100 New
100 $0
Q1 2022

May 03, 2022

BUY
$1.21 - $2.0 $121 - $200
100 New
100 $0

Others Institutions Holding NYMX

About NYMOX PHARMACEUTICAL CORP


  • Ticker NYMX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 91,265,000
  • Market Cap $42.9M
  • Description
  • Nymox Pharmaceutical Corporation, a biopharmaceutical company, engages in the research and development of drugs for the aging population in Canada, the United States, Europe, and internationally. Its lead drug candidate is Fexapotide Triflutate (NX-1207), which has completed Phase III clinical trials for the treatment of benign prostatic hyperpl...
More about NYMX
Track This Portfolio

Track Steward Financial Group LLC Portfolio

Follow Steward Financial Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Steward Financial Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Steward Financial Group LLC with notifications on news.